Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Unusual Machines Inc. Common Stock (UMAC) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Unusual Machines Inc. Common StockTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Unusual Machines Inc. Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? Unusual Machines Inc. Common Stock trades at $17.05 (market cap $885.73M), while State Street SPDR S&P Biotech ETF trades at $147.16 (market cap $10.05B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 11.3× Unusual Machines Inc. Common Stock's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Unusual Machines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Unusual Machines Inc. Common Stock for 0 Days and State Street SPDR S&P Biotech ETF for 39 Days on average.

UMACXBI
Market Cap
$885.73M$10.05B
Volume
3,688,53310,367,649
Sector
TechnologyBroad Market / Factor
52-Week High
$34.06$169.55
52-Week Low
$7.76$107.32
Typical Hold Time
0 Days39 Days
Enterprise Value
$572.51M—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Unusual Machines Inc. Common Stock

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $146.8, down 3.04% today amid a bearish technical signal. The ETF's modified equal-weight structure provides exposure to over 150 biotech names, benefiting from M&A activity and positive clinical catalysts. Recent news highlights a 76% prior-year rally and optimism around cancer vaccine breakthroughs from Merck and Moderna. However, the ETF carries higher volatility and expense ratios compared to broader healthcare funds.

Outlook remains mixed with technical indicators bearish but fundamental catalysts present. Investment opportunity lies in targeted biotech exposure and sector innovation, though risks include high volatility, regulatory uncertainty, and reliance on clinical trial successes. Analyst consensus is neutral with 100% hold rating, suggesting cautious optimism amid recent price declines.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

UMAC
100% Buy0% Sell
Avg holding period · 0 Days
XBI
100% Buy0% Sell
Avg holding period · 39 Days

Top news

Latest headlines on both assets

About Unusual Machines Inc. Common Stock

Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.

Read more on UMAC →

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI →